tiprankstipranks
Puma Biotechnology (PBYI)
NASDAQ:PBYI
US Market
PBYI
Puma Biotechnology
RESEARCH TOOLSreports
Want to see PBYI full AI Analyst Report?

Puma Biotechnology (PBYI) Income Statement

670 Followers

Puma Biotechnology Income Statement

Last quarter (Q4 2025), Puma Biotechnology's total revenue was $75.50M, an increase of 27.80% from the same quarter last year. In Q4, Puma Biotechnology's net income was $13.40M. See Puma Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 228.37M$ 230.47M$ 235.64M$ 228.03M$ 253.16M
Gross Profit
$ 170.21M$ 166.06M$ 172.96M$ 172.94M$ 189.45M
Operating Expenses
$ 132.91M$ 135.10M$ 140.31M$ 149.22M$ 188.16M
Depreciation and Amortization
$ 10.94M$ 11.52M$ 11.52M$ 9.84M$ 11.30M
EBITDA
$ 53.34M$ 48.08M$ 47.52M$ 21.89M$ -4.69M
Operating Income
$ 37.30M$ 30.97M$ 32.64M$ 23.72M$ 1.29M
Other Income/Expenses
$ -1.52M$ -6.87M$ -9.97M$ -23.26M$ -30.09M
Pretax Income
$ 35.78M$ 24.10M$ 22.67M$ 457.00K$ -28.80M
Net Income
$ 31.11M$ 30.28M$ 21.59M$ 2.00K$ -29.13M
Per Share Metrics
Basic EPS
$ 0.62$ 0.62$ 0.46$ 0.02$ -0.72
Diluted EPS
$ 0.61$ 0.62$ 0.45$ 0.02$ -0.72
Weighted Average Shares Outstanding
 50.01M 48.65M 47.13M 44.67M 40.64M
Weighted Average Shares Outstanding (Diluted)
 50.65M 49.10M 47.55M 44.93M 40.64M
Currency in USD

Puma Biotechnology Earnings and Revenue History